Salute e Benessere

ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal…

RSV is a leading cause of acute lower respiratory tract infections (ALRTI) in children under 5 years of age worldwide. More than 80% of children become infected before their first birthday, and nearly all have been exposed at age two. Among those infected, approximately one-third may develop severe ALRTI, such as bronchiolitis or pneumonia. Infants under one year of age, particularly preterm infants, are at greatest risk of developing serious RSV-related complications, often requiring…
PR Newswire
30/10/2025

DBV Technologies Announces Sale of approximately $30 million of ADSs Through its…

DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company”), a clinical-stage biopharmaceutical company, today announced that, pursuant to the Company’s At-The-Market program established on September 5, 2025 (the “ATM Program”), it has agreed to issue and sell new ordinary shares (the “Ordinary Shares”) in the form of American...
Nasdaq GlobeNewswire
29/10/2025

Postoperative Ileus Market to Advance Moderately During the Forecast Period…

Postoperative Ileus Market Summary Postoperative Ileus Market Summary Discover the postoperative ileus new treatment @New Treatments for Postoperative Ileus Key Factors Driving the Growth of the Postoperative Ileus Market High Clinical and Economic Burden of Postoperative Ileus Postoperative ileus substantially increases length of stay, readmissions and per-patient hospital costs after abdominal and colorectal surgery, creating a strong financial incentive for...
PR Newswire
29/10/2025

Surgical Sutures Market to Reach USD 7,923.8 million by 2032, Growing At An…

Browse bthe report and understand how it can benefit your business strategy - https://www.credenceresearch.com/report/surgical-sutures-market Browse bthe report and understand how it can benefit your business strategy -https://www.credenceresearch.com/report/surgical-sutures-market Market Overview The Surgical Sutures Market comprises one of the most fundamental and widely used categories of medical devices. A surgical suture is a thread used to hold body tissues together after an...
PR Newswire
29/10/2025

Silver Wound Dressing Market to Reach USD 2,129.8 million by 2032, Growing At An…

Browse the report and understand how it can benefit your business strategy - https://www.credenceresearch.com/report/silver-wound-dressing-market Browse the report and understand how it can benefit your business strategy -https://www.credenceresearch.com/report/silver-wound-dressing-market Market Overview The Silver Wound Dressing Market encompasses a specialized category of advanced wound care products impregnated with elemental silver or a silver compound. These dressings are...
PR Newswire
29/10/2025

Sepsis Diagnostics Market to Reach USD 1,790.9 million by 2032, Growing At An…

Browse the report and understand how it can benefit your business strategy - https://www.credenceresearch.com/report/sepsis-diagnostics-market Browse the report and understand how it can benefit your business strategy -https://www.credenceresearch.com/report/sepsis-diagnostics-market Market Overview Sepsis is a life-threatening condition characterized by the body's dysregulated and extreme response to an infection, leading to organ dysfunction and failure. It is a medical emergency...
PR Newswire
29/10/2025

Digital Pathology Market Size to Surpass USD 6.55 Billion by 2035, Rising at a…

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.vantagemarketresearch.com/digital-pathology-market-1445/request-sample The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.vantagemarketresearch.com/digital-pathology-market-1445/request-sample Free Sample Includes: Why CXOs and Decision-Makers Should Prioritize Digital Pathology Technological and Market...
PR Newswire
29/10/2025

Hansa hosts call with distinguished transplant surgeons: Insights on clinical…

About Robert Montgomery, MD, PhD AboutRobert Montgomery, MD, PhD Dr.Robert Montgomeryis Chair of the Department of Surgery and Director of the NYU Langone Transplant Institute. As a pioneer and international expert in desensitization, he has taken part in numerous research studies, publications, and has received many awards for his work. Throughout his career, Dr. Montgomery has led innovation in transplantation, credited with developing and performing the first 'domino paired...
PR Newswire
29/10/2025

RAMSAY SANTE : availability of the Universal Registration Document 2025

PRESS RELEASE Paris, 29 thOctober 2025 AVAILABILITY OF THE UNIVERSAL REGISTRATION DOCUMENT 2025 Ramsay Générale de Santé's 2025 Universal Registration Document was filed with the Autorité des marchés financiers (AMF) in ESEF format (European Single Electronic Format) on Wednesday 29 October 2025, under number D.25-0689. It is available to the public under the conditions provided for by the regulations in force; can be consulted on the Ramsay Santé website:...
Nasdaq GlobeNewswire
29/10/2025

Casino Group Communication

Casino Group Communication Paris, 29 October 2025Further to the article published today by Olivier Dauvers entitled “Casino: Kretinsky réinjecte de l’oxygène” (“Casino: Kretinsky injects new life”), Casino Group categorically denies the information that Daniel Kretinsky has “ injected €500 million into the retailer's accounts.” ***ANALYSTS AND INVESTORS CONTACTSCharlotte IZABEL-cizabel@groupe-casino.fr- Tél : +33 (0)6 89 19 88 33IR_Casino@groupe-casino.fr- Tél : +33...
Nasdaq GlobeNewswire
29/10/2025

Jungbunzlauer Tricalcium Citrate Excipient Demonstrates Outstanding Results in…

"This collaboration with Professor Wagner and his workgroup from the Department of Pharmaceutical Technology and Biopharmaceutics at the University of Bonn underscores our commitment to rigorous science, innovation and product excellence," said Markus Gerhart, Senior Director Category Lead Minerals & Solutions at Jungbunzlauer. "Through validated research, we're proud to demonstrate that our TCC TB delivers reliable performance in direct compression, helping our customers…
PR Newswire
29/10/2025

Herb Extract Market to Reach $23.8 billion, Globally, by 2035 at 9.3% CAGR…

Request Sample of the Report on Herb Extract Market Forecast 2034 – https://www.alliedmarketresearch.com/request-sample/A194451 Request Sample of the Report on Herb Extract Market Forecast 2034 –https://www.alliedmarketresearch.com/request-sample/A194451 Market Introduction Herb extracts are natural bioactive compounds derived from plants, widely used in dietary supplements, pharmaceuticals, cosmetics, and food & beverages for their therapeutic, nutritional, and functional...
PR Newswire
29/10/2025

Novartis ianalumab first drug to reduce disease activity and patient burden in…

NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective of reduced disease activity and provided clinically meaningful benefit 1 Data showed consistent improvements across secondary outcome measures, and a favorable safety profile 1 Novartis plans to submit to health authorities globally in early 2026 If approved, ianalumab could become first targeted treatment for this heterogeneous, systemic autoimmune diseaseBasel, October 29, 2025– Novartis today...
Nasdaq GlobeNewswire
29/10/2025

Clinical Analytics Market worth $81.32 billion by 2030 with 19.7% CAGR |…

Browse in-depth TOC on "Clinical Analytics Market" Browse in-depth TOC on "Clinical Analytics Market" 400 - Tables 50 - Figures 400 - Pages By use case,the healthcare use case segment accounted for significant growth in the clinical analytics market in 2024, driven by the increasing adoption of value-based care models and the growing demand for data-driven decision-making to improve patient outcomes. Healthcare providers are leveraging clinical analytics for clinical...
PR Newswire
29/10/2025

Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's…

"We are excited to partner with Nitto Denko Avecia, a recognized leader in therapeutic oligonucleotide manufacturing," said Stephen Dilly, MBBS, PhD, Chairman and Chief Executive Officer at Codexis. "This collaboration represents a significant milestone toward expanding the reach of our ECO Synthesis® Manufacturing Platform, through best-in-class CDMO collaborations." "We are excited to partner with Nitto Denko Avecia, a recognized leader in therapeutic oligonucleotide…
PR Newswire
29/10/2025

VentureMed Group Closes $28M Series C Funding to Accelerate Commercial Adoption…

In addition to expanded commercial infrastructure, the funding will also advance VentureMed's clinical program and support new product development, including new applications in adjacent vascular settings. In addition to expanded commercial infrastructure, the funding will also advance VentureMed's clinical program and support new product development, including new applications in adjacent vascular settings. "VentureMed is addressing one of the most persistent challenges in vascular…
PR Newswire
29/10/2025

Study Finds ELISAs in Milk Samples Less Reliable for Johne's Disease Detection…

Johne's disease costs the U.S. dairy industry an estimated $198 million annually (Journal of Dairy Science, Rasmussen et al., 2021). The disease, caused by the bacterium Mycobacterium avium subspecies paratuberculosis (MAP), progressively damages the gut of infected cattle, reducing nutrient absorption and milk yield. It spreads primarily through contaminated feces, milk or feed. Johne's disease costs the U.S. dairy industry an estimated$198 millionannually (Journal of Dairy Science,...
PR Newswire
29/10/2025

Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability

Click here to view the custom infographic of the Oncotelic Therapeutics editorial. Clickhere to view the custom infographic of the Oncotelic Therapeutics editorial. The pharmaceutical sector is at a critical turning point as it becomes increasingly clearthat even the most powerful cancer treatments depend on how effectively they reach tumors in therapeutic concentrations. Many promising oncology drugs underperform not because of inadequate mechanisms of action but because only a small...
PR Newswire
29/10/2025

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

COPENHAGEN, Denmark, October 29, 2025– Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5.20% of the shares and voting rights in Bavarian Nordic A/S as of October 23, 2025.About Bavarian NordicBavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox...
Nasdaq GlobeNewswire
29/10/2025

"World Hair Transplant Repair Day" Taking Place on 11/11 Shines Light on…

Case in point: earlier this month, Dubai police arrested a man running an illegal hair transplant clinic from an apartment. Case in point: earlier this month,Dubaipolice arrested a man running an illegal hair transplant clinic from an apartment. "These fraudulent, illicit hair transplant clinics operate under the guise of an established medical practice, luring unsuspecting patients with false or misleading advertising, rock-bottom prices and tempting travel packages," saidConradin…
PR Newswire
29/10/2025

Grupo Elfa and NUPCO sign agreement to support Saudi healthcare ecosystem with…

The MoU focuses on exploring joint opportunities in healthcare procurement, logistics, and digital efficiency, with an initial emphasis on the direct sourcing of medical disposables. NUPCO, as the national healthcare procurement and distribution hub, provides unparalleled access to an extensive network of hospitals, pharmacies, and warehousing infrastructure across Saudi Arabia. This partnership will connect NUPCO to Grupo Elfa's trusted global supplier network, diversifying sourcing channels…
PR Newswire
29/10/2025

Lycored Debuts New VAS Technology at SupplySide Global

Lycobeads VAS TM 10% is a leading formulation within the new VAS portfolio featuring lycopene, a standout nutraceutical ingredient renowned for its powerful antioxidant activity and its role in supporting cardiovascular health, skin protection and prostate function. Overall, VAS is a universal go-to solution that simplifies and streamlines formulation with one consistently high-performing product. Lycobeads VAS TM 10% is a leading formulation within the new VAS portfolio featuring lycopene, a...
PR Newswire
29/10/2025

Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting…

TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced its participation as a presenting company at BIO-Europe 2025. The event, Europe’s premier life sciences partnering conference, will take place November 3–5, 2025, at the Vienna Exhibition and Congress Center (Messe Wien) in Vienna, Austria.Tiziana’s management...
Nasdaq GlobeNewswire
29/10/2025

OKYO Pharma to Present at BIO-Europe 2025 in Vienna

LONDON and NEW YORK, Oct.29, 2025(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO ), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA approved therapy, and for inflammatory eye diseases, announced that Gary S. Jacob, Ph.D., Chief Executive Officer of OKYO Pharma, will present at the 33rd Annual BIO-Europe partnering conference in Vienna, Austria.BIO-Europe, one of the...
Nasdaq GlobeNewswire
29/10/2025
Altri  Comunicati